Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer - Hammer, S; Hagemann, UB; Zitzmann-Kolbe, S; Larsen, A; Ellingsen, C; Geraudie, S (Clin Cancer Res, 2020)
et al.